COGENTIS THERAPEUTICS
Cogentis Therapeutics they develops therapeutics that prevent neurodegeneration and restore brain function to benefit the lives of those patients and their families.
COGENTIS THERAPEUTICS
Industry:
Biotechnology Health Care Personal Health Service Industry
Founded:
2015-05-26
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.cogentistherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
443.842.6856
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Google Apps For Business Typekit
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE
ISCRM is working to transform therapies for heart failure, neurodegenerative diseases.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Proclara Biosciences
Proclara is pioneering a new approach to treating neurodegenerative diseases.
Roskamp Institute
Roskamp Institute is an organization that is dedicated to finding cures for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Cogentis Therapeutics
Official Site Inspections
http://www.cogentistherapeutics.com Semrush global rank: 8.92 M Semrush visits lastest month: 232
- Host name: server197-3.web-hosting.com
- IP address: 198.54.115.202
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Cogentis Therapeutics"
Cogentis Therapeutics
Cogentis is committed to finding cures for multiple neurodegenerative diseases including but not limited to Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, and …See details»
About – Cogentis Therapeutics
Cogentis discovers and develops first-in-class therapeutics that prevent neurodegeneration and restore brain function to benefit the lives of those patients and their families.See details»
Cogentis Therapeutics - Crunchbase Company Profile & Funding
Cogentis Therapeutics is a Biotechnology Company. View contacts for Cogentis Therapeutics to access new leads and connect with decision-makers.See details»
Cogentis Therapeutics, Inc. - LinkedIn
Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying therapeutic for dementias such as …See details»
Cogentis Therapeutics, Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cogentis Therapeutics, Inc of Columbia, MD. Get the latest business insights from Dun & Bradstreet.See details»
Cogentis Therapeutics Company Profile | Management and
Cogentis Therapeutics Profile and History. Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying …See details»
Cogentis Therapeutics, Inc. Information - RocketReach
Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying therapeutic for dementias such as …See details»
Cogentis Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Cogentis Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Endocrinology and Metabolic Disease, Nervous ...See details»
Cogentis Therapeutics | VentureRadar
Website: http://www.cogentistherapeutics.com/ Develops a platform targeting dementia and neurodegenerative diseases, with a lead therapeutic, CT-526, that reverses ...See details»
Cogentis Therapeutics - Products, Competitors, Financials, …
Cogentis Therapeutics is a biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases. Use the CB Insights Platform to explore …See details»
Cogentis Therapeutics - VentureRadar
Similar Companies: Alteron Therapeutics USA Privately Held Alteron Therapeutics is a biopharmaceutical company dedicated to developing TDP-43 inhibitors for the treatment of …See details»
Cogentis Therapeutics - Craft
Cogentis Therapeutics is a company that develops therapeutics to prevent neurodegeneration and restore brain function. It focuses on neurodegenerative disorders such as Alzheimer's …See details»
Cogentis Therapeutics, Inc. - Company Profile & Staff ... - ContactOut
Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying therapeutic for dementias such as …See details»
Cogentis Therapeutics, Inc. — MIT-CHIEF
Nov 16, 2017 Cogentis is a pre-clinical, pre-money biotech working with the NIH and academia to cure Alzheimer’s Disease. We are developing an unprecedented patented therapy that …See details»
Cogentis Therapeutics - PitchBook
Cogentis Therapeutics General Information Description. Developer of disease-modifying therapeutics intended to find cures for several neurodegenerative diseases. The company …See details»
Cogentis Therapeutics - Overview, News & Similar companies
View Cogentis Therapeutics (www.cogentistx.com) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Contact - Cogentis Therapeutics
If you are interested in partnering with Cogentis or have any questions or comments, please fill out the form or contact us at [email protected]See details»
Cogentis Therapeutics - Overview, News & Similar companies
Cogentis Therapeutics contact info: Phone number: (443) 842-6856 Website: www.cogentistherapeutics.com What does Cogentis Therapeutics do? Cogentis Therapeutics …See details»
Cogentis Therapeutics | CipherBio
Explore Cogentis Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Research - Cogentis Therapeutics
Shukla V et al. TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.J Alzheimers Dis. …See details»